KRAS and melanoma: A recent study suggests that overexpression of PDE4 enzymes is critical for the MAPK activation by oncogenic-RAS in melanoma cells [15], indicating the novel strategy targeting PDE4 activity in melanoma cells with oncogenic KRAS.